Primary |
Product Used For Unknown Indication |
26.4% |
Drug Use For Unknown Indication |
15.1% |
Pain |
8.6% |
Pyrexia |
8.5% |
Arthritis |
6.3% |
Headache |
6.1% |
Hypertension |
4.4% |
Nasopharyngitis |
4.2% |
Arthralgia |
3.4% |
Upper Respiratory Tract Infection |
2.2% |
Accidental Exposure |
2.0% |
Back Pain |
1.9% |
Premedication |
1.8% |
Analgesic Therapy |
1.6% |
Diabetes Mellitus |
1.4% |
Myalgia |
1.4% |
Influenza |
1.2% |
Migraine |
1.2% |
Depression |
1.1% |
Medical Diet |
1.1% |
|
Product Quality Issue |
20.5% |
Vomiting |
18.3% |
Overdose |
7.5% |
Transmission Of An Infectious Agent Via A Medicinal Product |
5.9% |
Toxicity To Various Agents |
5.3% |
Weight Decreased |
5.3% |
Hepatic Failure |
5.0% |
Intentional Overdose |
4.3% |
Suicide Attempt |
4.0% |
Hypersensitivity |
3.1% |
Convulsion |
2.8% |
Liver Injury |
2.5% |
Acute Hepatic Failure |
2.2% |
Rectal Haemorrhage |
2.2% |
Toxic Epidermal Necrolysis |
2.2% |
Urticaria |
2.2% |
Hepatic Cirrhosis |
1.9% |
Medication Error |
1.9% |
Death |
1.6% |
Intentional Drug Misuse |
1.6% |
|
Secondary |
Product Used For Unknown Indication |
19.5% |
Drug Use For Unknown Indication |
13.8% |
Pain |
13.5% |
Pyrexia |
6.6% |
Headache |
6.2% |
Foetal Exposure During Pregnancy |
5.8% |
Premedication |
5.2% |
Arthritis |
4.6% |
Hypertension |
3.2% |
Migraine |
2.7% |
Rheumatoid Arthritis |
2.6% |
Arthralgia |
2.4% |
Back Pain |
2.1% |
Crohn's Disease |
1.8% |
Depression |
1.8% |
Diabetes Mellitus |
1.6% |
Fibromyalgia |
1.6% |
Nasopharyngitis |
1.6% |
Blood Cholesterol Increased |
1.5% |
Musculoskeletal Pain |
1.5% |
|
Vomiting |
21.1% |
Product Quality Issue |
13.0% |
Drug Ineffective |
8.8% |
Suicide Attempt |
7.8% |
Overdose |
5.5% |
Weight Decreased |
4.7% |
Drug Hypersensitivity |
3.8% |
Pyrexia |
3.8% |
Intentional Overdose |
3.3% |
Urticaria |
3.3% |
Hepatic Failure |
3.2% |
Transmission Of An Infectious Agent Via A Medicinal Product |
3.2% |
White Blood Cell Count Decreased |
3.2% |
Somnolence |
3.0% |
Toxicity To Various Agents |
2.5% |
Hypersensitivity |
2.2% |
Pain |
2.0% |
Rectal Haemorrhage |
2.0% |
Nausea |
1.8% |
Toxic Epidermal Necrolysis |
1.8% |
|
Concomitant |
Product Used For Unknown Indication |
26.7% |
Drug Use For Unknown Indication |
14.9% |
Premedication |
9.2% |
Pain |
8.5% |
Hypertension |
4.8% |
Rheumatoid Arthritis |
4.4% |
Crohn's Disease |
3.9% |
Depression |
3.4% |
Multiple Sclerosis |
3.2% |
Headache |
2.5% |
Gastrooesophageal Reflux Disease |
2.3% |
Anxiety |
2.3% |
Nausea |
2.0% |
Asthma |
2.0% |
Prophylaxis |
1.9% |
Arthritis |
1.8% |
Hepatitis C |
1.7% |
Constipation |
1.6% |
Insomnia |
1.6% |
Back Pain |
1.3% |
|
Vomiting |
17.2% |
Weight Decreased |
10.5% |
Weight Increased |
6.9% |
Pain |
6.3% |
Pulmonary Embolism |
5.9% |
Urinary Tract Infection |
5.7% |
Nausea |
4.1% |
Drug Ineffective |
4.0% |
Pyrexia |
4.0% |
Rash |
3.6% |
Tremor |
3.6% |
Ventricular Septal Defect |
3.3% |
White Blood Cell Count Decreased |
3.3% |
Pneumonia |
3.2% |
Pain In Extremity |
3.2% |
Death |
3.1% |
Vision Blurred |
3.1% |
Thrombocytopenia |
3.0% |
Urticaria |
3.0% |
White Blood Cell Count Increased |
3.0% |
|
Interacting |
Product Used For Unknown Indication |
29.7% |
Pain |
13.5% |
Arthritis |
8.1% |
Fibromyalgia |
5.4% |
Sleep Disorder |
5.4% |
Arthralgia |
2.7% |
Arthropathy |
2.7% |
Bursitis |
2.7% |
Chronic Myeloid Leukaemia |
2.7% |
Headache |
2.7% |
Hormone Level Abnormal |
2.7% |
Migraine |
2.7% |
Neuropathy Peripheral |
2.7% |
Pain In Extremity |
2.7% |
Pancreatic Carcinoma |
2.7% |
Pyrexia |
2.7% |
Smoking Cessation Therapy |
2.7% |
Temporal Lobe Epilepsy |
2.7% |
Thyroid Disorder |
2.7% |
|
Drug Interaction |
9.1% |
Headache |
9.1% |
Menorrhagia |
9.1% |
Oropharyngeal Pain |
9.1% |
Pain |
9.1% |
Pyrexia |
9.1% |
Rash |
9.1% |
Status Epilepticus |
9.1% |
Tinnitus |
9.1% |
Weight Increased |
9.1% |
Wound |
9.1% |
|